Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Proteomics. Clinical Applications
|
December 11, 2013
The future of targeted peptidomics
Peter Findeisen
Proteomics. Clinical Applications
|
January 4, 2012
Functional protease profiling for diagnosis of malignant disease
Peter Findeisen, Michael Neumaier
Clinical Chemistry and Laboratory Medicine
|
May 19, 2009
Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
Peter Findeisen, Michael Neumaier
Proteomics. Clinical Applications
|
June 11, 2014
Proteases and disease
Oliver Schilling, Peter Findeisen
Expert Review of Proteomics
|
October 9, 2009
Mass spectrometry-based clinical proteomics profiling: current status and future directions
Peter Findeisen, Michael Neumaier
Proteomics. Clinical Applications
|
April 11, 2016
Clinical applications of MS-based protein quantification
Bassel Sabbagh, Sonani Mindt, Michael Neumaier, et al.
Practical Laboratory Medicine
|
September 23, 2024
Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer
Ulla Ruffing, Sabrina Mickeler, Michaela Kraft, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Fluoxetine Enhances Synaptic Vesicle Trafficking and Energy Metabolism in the Hippocampus of Socially Isolated Rats
Dragana Filipović, Victor Costina, Peter Findeisen, et al.
Clinical Chemistry
|
September 22, 2007
Addition of exogenous reporter peptides to serum samples before mass spectrometry-based protease profiling provides advantages over profiling of endogenous peptides
Peter Findeisen, Stefan Post, Frederik Wenz, et al.
Clinical Chemistry and Laboratory Medicine
|
August 22, 2025
Method comparison of diabetes mellitus associated autoantibodies in serum specimens
Alexander Lenard, Andreas Rapp, Steffen Busch, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Proteomics. Clinical Applications
|
December 11, 2013
The future of targeted peptidomics
Peter Findeisen
Proteomics. Clinical Applications
|
January 4, 2012
Functional protease profiling for diagnosis of malignant disease
Peter Findeisen, Michael Neumaier
Clinical Chemistry and Laboratory Medicine
|
May 19, 2009
Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
Peter Findeisen, Michael Neumaier
Proteomics. Clinical Applications
|
June 11, 2014
Proteases and disease
Oliver Schilling, Peter Findeisen
Expert Review of Proteomics
|
October 9, 2009
Mass spectrometry-based clinical proteomics profiling: current status and future directions
Peter Findeisen, Michael Neumaier
Proteomics. Clinical Applications
|
April 11, 2016
Clinical applications of MS-based protein quantification
Bassel Sabbagh, Sonani Mindt, Michael Neumaier, et al.
Practical Laboratory Medicine
|
September 23, 2024
Analytical performance evaluation of a new integrated clinical chemistry and immunoassay analyzer
Ulla Ruffing, Sabrina Mickeler, Michaela Kraft, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Fluoxetine Enhances Synaptic Vesicle Trafficking and Energy Metabolism in the Hippocampus of Socially Isolated Rats
Dragana Filipović, Victor Costina, Peter Findeisen, et al.
Clinical Chemistry
|
September 22, 2007
Addition of exogenous reporter peptides to serum samples before mass spectrometry-based protease profiling provides advantages over profiling of endogenous peptides
Peter Findeisen, Stefan Post, Frederik Wenz, et al.
Clinical Chemistry and Laboratory Medicine
|
August 22, 2025
Method comparison of diabetes mellitus associated autoantibodies in serum specimens
Alexander Lenard, Andreas Rapp, Steffen Busch, et al.
Page
of 9